Profilo
Alex Mercer worked as the Director of Clinical Development at Calliditas Therapeutics AB and as the Head of Discovery at Newron Sweden AB from 2000 to 2010.
He holds a doctorate degree from University College London.
Precedenti posizioni note di Alex Mercer
| Società | Posizione | Fine |
|---|---|---|
Newron Sweden AB
 Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Corporate Officer/Principal | - |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | - |
Formazione di Alex Mercer
| University College London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| Aziende private | 1 |
|---|---|
Newron Sweden AB
Newron Sweden AB Pharmaceuticals: MajorHealth Technology Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden. | Health Technology |
- Borsa valori
- Insiders
- Alex Mercer
